# David P. Walling, Ph.D., Garden Grove, CA – FDA Inspections

Source: https://www.keypedia.com/companies/david-p-walling-phd/9e1c45b0-e599-4f02-b965-72551a0d70b6

> Inspection records and compliance data for David P. Walling, Ph.D. in Garden Grove, California. 8 FDA inspections on record, last inspected January 13, 2023.

---

## Details

- Name: David P. Walling, Ph.D.
- FEI Number: 3008743025
- Address Line 1: 12772 Valley View St
- City: Garden Grove
- State: California
- Zip Code: 92845
- Country Name: United States
- Address: 12772 Valley View St, Garden Grove, California 92845, United States
- Country: United States

## Related Documents

- [FDA Inspection 1195349 - David P. Walling, Ph.D. - 2023-01-13](https://www.keypedia.com/records/fda_inspections/david-p-walling-phd/57c57951-6596-4170-b00f-3c4d9f4e7df5) — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 13, 2023
- [FDA Inspection 1143823 - David P. Walling, Ph.D. - 2021-05-14](https://www.keypedia.com/records/fda_inspections/david-p-walling-phd/54182797-6a79-4873-bd3e-4a0388d50a92) — classification: No Action Indicated (NAI), source: FDA, date: May 14, 2021
- FDA Inspection 1063079 - David P. Walling, Ph.D. - 2018-03-19 — classification: No Action Indicated (NAI), source: FDA, date: March 19, 2018
- FDA Inspection 917428 - David P. Walling, Ph.D. - 2015-03-11 — classification: No Action Indicated (NAI), source: FDA, date: March 11, 2015
- FDA Inspection 911140 - David P. Walling, Ph.D. - 2015-01-23 — classification: No Action Indicated (NAI), source: FDA, date: January 23, 2015
- FDA Inspection 879347 - David P. Walling, Ph.D. - 2014-05-09 — classification: No Action Indicated (NAI), source: FDA, date: May 9, 2014
- [FDA Inspection 874815 - David P. Walling, Ph.D. - 2014-04-16](https://www.keypedia.com/records/fda_inspections/david-p-walling-phd/c979e17f-6b2d-41d7-bb8a-59f06ece08e4) — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 16, 2014
- FDA Inspection 810123 - David P. Walling, Ph.D. - 2012-12-17 — classification: No Action Indicated (NAI), source: FDA, date: December 17, 2012

## Related Companies

- [Fessel, W. Jeffrey M.D.](https://www.keypedia.com/companies/fessel-w-jeffrey-md/2f6fbd80-164c-4bc0-a903-fca9c2270e8c)
- [Cheung, Deanna G MD](https://www.keypedia.com/companies/cheung-deanna-g-md/9e5cedf8-1cc3-4484-9d10-79b6788d1f7b)
- [Robert Boostanfar](https://www.keypedia.com/companies/robert-boostanfar/b4494913-e79a-42ce-ab9e-41b05c3bd4c7)
- [Epi Center Med Spa](https://www.keypedia.com/companies/epi-center-med-spa/60fc3e8d-f850-4e5c-9ccd-a0802a955226)
- [Hipolito Mariano, Jr., M.D.](https://www.keypedia.com/companies/hipolito-mariano-jr-md/2b359e46-74b3-43f5-86f0-1ea53398768a)
- [Anne Lynn Su Chang, M.D.](https://www.keypedia.com/companies/anne-lynn-su-chang-md/add49aba-18b5-4ae6-b182-58f6c773e363)
- [Dula, Eugene Md](https://www.keypedia.com/companies/dula-eugene-md/6484c00e-c7f7-43e4-ac06-d10570c9e322)
- [Jason C. Bermak, M.D., Ph.D.](https://www.keypedia.com/companies/jason-c-bermak-md-phd/9cda6c34-2a6c-4a02-baad-2c0d7d7e9b40)
- [Sarbani Maitra, M.D.](https://www.keypedia.com/companies/sarbani-maitra-md/cb120988-797b-4dfd-be3c-4deb99ff907d)
- [Lawrence A. Osman, M.D](https://www.keypedia.com/companies/lawrence-a-osman-md/3d7ee4e7-d716-4d0e-831d-3031af34a68a)